BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 11602320)

  • 1. Flt3 ligand and granulocyte-macrophage colony-stimulating factor preferentially expand and stimulate different dendritic and T-cell subsets.
    Parajuli P; Mosley RL; Pisarev V; Chavez J; Ulrich A; Varney M; Singh RK; Talmadge JE
    Exp Hematol; 2001 Oct; 29(10):1185-93. PubMed ID: 11602320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple signals are required for maturation of human dendritic cells mobilized in vivo with Flt3 ligand.
    Mosca PJ; Hobeika AC; Colling K; Clay TM; Thomas EK; Caron D; Lyerly HK; Morse MA
    J Leukoc Biol; 2002 Sep; 72(3):546-53. PubMed ID: 12223523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified.
    Maraskovsky E; Brasel K; Teepe M; Roux ER; Lyman SD; Shortman K; McKenna HJ
    J Exp Med; 1996 Nov; 184(5):1953-62. PubMed ID: 8920882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal in vitro culture conditions for murine predominant immature CD8a+ dendritic cells.
    Na N; Xu L; Cao KY; Luo Y; Yuan GQ; Xiang P; Hong LQ; Li SN
    Chin Med J (Engl); 2009 Feb; 122(3):344-8. PubMed ID: 19236816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditis.
    Vasu C; Dogan RN; Holterman MJ; Prabhakar BS
    J Immunol; 2003 Jun; 170(11):5511-22. PubMed ID: 12759428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory response.
    Eksioglu EA; Mahmood SS; Chang M; Reddy V
    Exp Hematol; 2007 Aug; 35(8):1163-71. PubMed ID: 17562355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8(+) T-cell cross-priming but is ineffective as a therapy.
    Berhanu A; Huang J; Alber SM; Watkins SC; Storkus WJ
    Cancer Res; 2006 May; 66(9):4895-903. PubMed ID: 16651446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-SCF.
    Daro E; Butz E; Smith J; Teepe M; Maliszewski CR; McKenna HJ
    Cytokine; 2002 Feb; 17(3):119-30. PubMed ID: 11895330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice.
    O'Keeffe M; Hochrein H; Vremec D; Pooley J; Evans R; Woulfe S; Shortman K
    Blood; 2002 Mar; 99(6):2122-30. PubMed ID: 11877288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-encoded fetal liver tyrosine kinase 3 ligand and granulocyte macrophage-colony-stimulating factor increase dendritic cell recruitment to the inoculation site and enhance antigen-specific CD4+ T cell responses induced by DNA vaccination of outbred animals.
    Mwangi W; Brown WC; Lewin HA; Howard CJ; Hope JC; Baszler TV; Caplazi P; Abbott J; Palmer GH
    J Immunol; 2002 Oct; 169(7):3837-46. PubMed ID: 12244180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat bone marrow-derived dendritic cells generated with GM-CSF/IL-4 or FLT3L exhibit distinct phenotypical and functional characteristics.
    N'diaye M; Warnecke A; Flytzani S; Abdelmagid N; Ruhrmann S; Olsson T; Jagodic M; Harris RA; Guerreiro-Cacais AO
    J Leukoc Biol; 2016 Mar; 99(3):437-46. PubMed ID: 26516183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses.
    Weigel BJ; Nath N; Taylor PA; Panoskaltsis-Mortari A; Chen W; Krieg AM; Brasel K; Blazar BR
    Blood; 2002 Dec; 100(12):4169-76. PubMed ID: 12393694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-alpha are potent inducers of HIV-specific CD8 T cells.
    Carbonneil C; Aouba A; Burgard M; Cardinaud S; Rouzioux C; Langlade-Demoyen P; Weiss L
    AIDS; 2003 Aug; 17(12):1731-40. PubMed ID: 12891059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PU.1 is essential for CD11c expression in CD8(+)/CD8(-) lymphoid and monocyte-derived dendritic cells during GM-CSF or FLT3L-induced differentiation.
    Zhu XJ; Yang ZF; Chen Y; Wang J; Rosmarin AG
    PLoS One; 2012; 7(12):e52141. PubMed ID: 23284905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo.
    Pulendran B; Banchereau J; Burkeholder S; Kraus E; Guinet E; Chalouni C; Caron D; Maliszewski C; Davoust J; Fay J; Palucka K
    J Immunol; 2000 Jul; 165(1):566-72. PubMed ID: 10861097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional, but not systemic recruitment/expansion of dendritic cells by a pluronic-formulated Flt3-ligand plasmid with vaccine adjuvant activity.
    Sang H; Pisarev VM; Munger C; Robinson S; Chavez J; Hatcher L; Parajuli P; Guo Y; Talmadge JE
    Vaccine; 2003 Jun; 21(21-22):3019-29. PubMed ID: 12798646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand.
    Daro E; Pulendran B; Brasel K; Teepe M; Pettit D; Lynch DH; Vremec D; Robb L; Shortman K; McKenna HJ; Maliszewski CR; Maraskovsky E
    J Immunol; 2000 Jul; 165(1):49-58. PubMed ID: 10861034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice.
    Björck P
    Blood; 2001 Dec; 98(13):3520-6. PubMed ID: 11739152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.